blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0375562

EP0375562 - Novel monoclonal antibody to human carcinomas [Right-click to bookmark this link]
Former [1990/26]Monoclonal antibody to human carcinomas
[1990/39]
StatusNo opposition filed within time limit
Status updated on  02.03.1996
Database last updated on 10.07.2024
Most recent event   Tooltip02.03.1996No opposition filed within time limitpublished on 17.04.1996 [1996/16]
Applicant(s)For all designated states
ONCOGEN LIMITED PARTNERSHIP
3005 First Avenue
Seattle, WA 98121 / US
[1990/26]
Inventor(s)01 / Hellstrom, Ingegerd
3925 N.E. Surber Drive
Seattle, WA 95105 / US
02 / Hellstrom, Karl Erik
3925 N.E. Surber Drive
Seattle, WA 95105 / US
[1990/26]
Representative(s)Warcoin, Jacques, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [1990/26]Warcoin, Jacques, et al
Cabinet Régimbeau, 26, avenue Kléber
F-75116 Paris / FR
Application number, filing date89403631.822.12.1989
[1990/26]
Priority number, dateUS1988028963522.12.1988         Original published format: US 289635
US1989044369629.11.1989         Original published format: US 443696
[1990/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0375562
Date:27.06.1990
Language:EN
[1990/26]
Type: A3 Search report 
No.:EP0375562
Date:12.09.1990
Language:EN
[1990/37]
Type: B1 Patent specification 
No.:EP0375562
Date:26.04.1995
Language:EN
[1995/17]
Search report(s)(Supplementary) European search report - dispatched on:EP24.07.1990
ClassificationIPC:C12P21/08, A61K39/395
[1990/37]
CPC:
C07K16/468 (EP,US); A61K47/6851 (EP,US); A61K47/6877 (EP,US);
A61K49/0004 (EP,US); A61P35/00 (EP); C07K16/30 (EP,US);
A61K38/00 (EP,US); C07K2317/732 (EP,US); C07K2317/77 (EP,US) (-)
Former IPC [1990/26]C12P21/08, A61K47/48, A61K39/395, A61K49/00
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1990/26]
TitleGerman:Neuer monoklonaler Antikörper gegen menschliches Karzinom[1995/17]
English:Novel monoclonal antibody to human carcinomas[1990/39]
French:Nouvel anticorps monoclonal pour les carcinomes humains[1995/17]
Former [1990/26]Monoklonaler Antikörper gegen menschliches Karzinom
Former [1990/26]Monoclonal antibody to human carcinomas
Former [1990/26]Anticorps monoclonal pour les carcinomes humains
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure21.01.1991Examination requested  [1991/12]
08.02.1993Despatch of a communication from the examining division (Time limit: M06)
02.08.1993Reply to a communication from the examining division
25.11.1993Despatch of a communication from the examining division (Time limit: M04)
17.01.1994Reply to a communication from the examining division
23.03.1994Despatch of communication of intention to grant (Approval: No)
29.09.1994Despatch of communication of intention to grant (Approval: later approval)
19.10.1994Communication of intention to grant the patent
24.01.1995Fee for grant paid
24.01.1995Fee for publishing/printing paid
Opposition(s)27.01.1996No opposition filed within time limit [1996/16]
Fees paidRenewal fee
30.12.1991Renewal fee patent year 03
23.11.1992Renewal fee patent year 04
29.11.1993Renewal fee patent year 05
19.12.1994Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]  - PROC. NATL. ACAD. SCI. USA, vol. 83, September 1986, pages 7059-7063; I. HELLSTRÖM et al.: "Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas" Page 7059: "Introduction"
 [YD]  - CANCER RESEARCH, vol. 46, August 1986, pages 3917-3923; I. HELLSTRÖM et al.: "Monoclonal mouse antibodies raised against human lung carcinoma" Page 3922, right-hand column
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.